Tofflon Science and Technology Group Co., Ltd. (SHE:300171)
China
· Delayed Price · Currency is CNY 13.19
-0.60 (-4.35%)
Apr 29, 2026, 3:04 PM CST
SHE:300171 Revenue
Tofflon Science and Technology Group had revenue of 1.11B CNY in the quarter ending March 31, 2026, a decrease of -2.54%. This brings the company's revenue in the last twelve months to 5.20B, up 3.28% year-over-year. In the year 2025, Tofflon Science and Technology Group had annual revenue of 5.23B with 4.45% growth.
Revenue (ttm)
5.20B
Revenue Growth
+3.28%
P/S Ratio
1.93
Revenue / Employee
960.68K
Employees
5,417
Market Cap
10.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.23B | 222.78M | 4.45% |
| Dec 31, 2024 | 5.01B | -631.55M | -11.19% |
| Dec 31, 2023 | 5.64B | 172.27M | 3.15% |
| Jan 1, 2023 | 5.47B | 1.28B | 30.46% |
| Jan 1, 2022 | 4.19B | 1.48B | 54.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sansure Biotech | 1.65B |
| Eyebright Medical Technology (Beijing) | 1.52B |
| Tinavi Medical Technologies | 283.26M |
| Allmed Medical Products Co.,Ltd | 3.67B |
| Autek China | 1.84B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |
| Qingdao NovelBeam Technology | 630.18M |
| Aidite (Qinhuangdao) Technology | 1.03B |